Company / Net Income
Day One Biopharmaceuticals, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$107.3M
FY2025
5-year range
-$188.9M / -$72.8M
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
#110 of 214
Health Care
What the data says
At -$107M, Day One Biopharmaceuticals, Inc.'s net income ranks #110 of 214 in the Health Care sector. Improved from -$189M to -$107M over the past 2 years.
Based on SEC 10-K filings.
-$107M in FY2025.
Improved from -$189M to -$107M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 214 in Health CareTop 51% of 214This company -$107.3M Sector average $442.7M
▼
-124.2% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 12.4% year-over-year.
- Ranks #110 out of 214 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2023.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$107.3M | -12.4% |
| FY2024 | -$95.5M | +49.5% |
| FY2023 | -$188.9M | -32.9% |
| FY2022 | -$142.2M | -95.4% |
| FY2021 | -$72.8M | -79.6% |
| FY2020 | -$40.5M | -220.6% |
| FY2019 | -$12.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026